Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
FOXO Technologies ( (FOXO) ) has issued an update.
FOXO Technologies Inc. has announced a special meeting for its shareholders on January 17, 2025, to seek approval for several proposals, including the issuance of shares of Class A Common Stock and possible changes in control as per NYSE American rules. The company’s CEO, Seamus Lagan, emphasizes the importance of these proposals in facilitating growth and increasing shareholder value, with a focus on revenue generation and potential acquisition opportunities.
More about FOXO Technologies
FOXO Technologies Inc. operates within the biotechnology sector, focusing on enhancing human health and lifespan through innovative technology and products. The company owns subsidiaries including Foxo Labs, Myrtle Recovery Centers, and Rennova Community Health, which engage in biotechnology, behavioral health services, and community healthcare, respectively.
YTD Price Performance: 0%
Average Trading Volume: 50,063,878
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $5.51M
Learn more about FOXO stock on TipRanks’ Stock Analysis page.
